Yahoo Finance

Cone Rod Dystrophy Market Research Report 2025-2035: Gene Editing and Collaborations Drive Innovations

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been ...
Business Wire

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

PARIS--(BUSINESS WIRE)--Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug ...
Nasdaq

Ocugen: FDA Grants Rare Pediatric Disease Designation For OCU410ST

(RTTNews) - Ocugen, Inc. (OCGN) announced the FDA has granted Rare Pediatric Disease Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis ...
Science Daily

Comparing nocturnal and diurnal rodents helps scientists understand a human eye disease

Light-sensitive cells in the retina come in two main types: rods and cones. Rods are used for vision at low light and cones for color and bright light. A study in the September issue of the Journal of ...
Mena FN

Cone Rod Dystrophy Market Research Report 2025-2035: Gene Editing And Collaborations Drive Innovations

(MENAFN- GlobeNewsWire - Nasdaq) Cone rod dystrophy is a rare inherited retinal disorder impacting cones and rods, leading to progressive vision loss. The market for cone rod dystrophy is poised for ...